HUTCHMED (China) (HCM) Net Equity Issued and Repurchased (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Net Equity Issued and Repurchased came in at $614.9 million in Q2 2021, up 253990.91% on a QoQ basis from $242000.0 in Q1 2021.
HUTCHMED (China) (HCM) Net Equity Issued and Repurchased (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $614.9 million in Q2 2021.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $614.9 million in Q2 2021; TTM through Jun 2021 was $614.9 million, a 405.84% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 99.75% from the prior year.
- Net Equity Issued and Repurchased for Q2 2021 stood at $614.9 million, up from $242000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for HCM reached as high as $614.9 million in Q2 2021 and fell as low as $24000.0 in Q3 2018.
- Historically, Net Equity Issued and Repurchased has averaged $92.2 million across 4 years, with a median of $360000.0 in 2018.
- Across the five-year window, Net Equity Issued and Repurchased slumped 96.93% in 2019 and tumbled 99.8% in 2021, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $3.1 million in 2018, then slumped by 96.93% to $96000.0 in 2019, then jumped by 123171.88% to $118.3 million in 2020, then soared by 419.6% to $614.9 million in 2021.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $614.9 million in Q2 2021, $242000.0 in Q1 2021, and $118.3 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 614.90 Mn |
| Jun 30, 2021 | 614.90 Mn |
| Mar 31, 2021 | 242,000.00 |
| Mar 31, 2021 | 242,000.00 |
| Mar 31, 2020 | 118.34 Mn |
| Mar 31, 2020 | 118.34 Mn |
| Dec 31, 2019 | 96,000.00 |
| Dec 31, 2019 | 96,000.00 |
| Dec 31, 2018 | 3.12 Mn |
| Dec 31, 2018 | 3.12 Mn |
| Sep 30, 2018 | 24,000.00 |
| Sep 30, 2018 | 24,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Mar 31, 2018 | 254,000.00 |
| Mar 31, 2018 | 254,000.00 |